Addressing buprenorphine supply barriers: A guidance commentary

The current supply-side constraints limiting buprenorphine availability at pharmacies may reduce the potential impact of recent initiatives to improve medications for opioid use disorder (MOUD) access. The recent opioid litigation combined with existing federal regulation and enforcement has resulte...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Pharmacists Association Vol. 64; no. 2; pp. 377 - 379
Main Authors Khail, Jordan W., Rawal, Smita, Young, Henry N., Caballero, Joshua
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2024
Subjects
Online AccessGet full text

Cover

Loading…